J. Judice

Chief Executive Officer at DICE THER

61 year

Health Technology

Consumer Services

Technology Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Jeffrey Stein	M	69	CIDARA THERAPEUTICS, INC.	10 years
Daniel Burgess	M	62	CIDARA THERAPEUTICS, INC.	10 years
Richard Scheller	M	70	DICE Molecules SV, Inc. DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. DiCE Molecules, Inc. DiCE Molecules, Inc. Packaged SoftwareTechnology Services DiCE Molecules, Inc. is a private company that focuses on immunology and small molecule discovery. The company is based in Menlo Park, CA. The company's goal is to provide convenient oral medicines with biologic-like efficacy to patients with chronic diseases. The company was founded by J. Kevin Judice and he has been the CEO since incorporation.	9 years
Theodore Schroeder	M	69	CIDARA THERAPEUTICS, INC.	10 years
Philip Johnson	M	59	DICE THER	1 years
Leslie Tari	M	57	CIDARA THERAPEUTICS, INC.	11 years
Michael Thompson	M	-	DICE THER	1 years
Sharon Tetlow	F	64	DICE Molecules SV, Inc. DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.	-
Jim Scopa	M	65	DICE Molecules SV, Inc. DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.	4 years
Jake Simson	M	38	DICE Molecules SV, Inc. DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.	3 years
Carmen Betancourt	F	-	CIDARA THERAPEUTICS, INC.	10 years
Stephen Zachary	M	42	DICE Molecules SV, Inc. DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.	-
Shaan Gandhi	M	38	DICE Molecules SV, Inc. DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.	4 years
Allison Lewis	F	-	CIDARA THERAPEUTICS, INC.	9 years
Gordon Brooks	M	-	DICE THER	1 years
Chris Anderson	M	-	DICE THER	1 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Kevin Forrest	M	47	CIDARA THERAPEUTICS, INC.	-
Scott Rocklage	M	69	CIDARA THERAPEUTICS, INC. ACHAOGEN	15 years
John C. Doyle	M	55	ACHAOGEN	10 years
Kenneth Hillan	M	63	ACHAOGEN	8 years
Bryan Roberts	M	57	ACHAOGEN	15 years
Christopher T. Walsh	M	80	ACHAOGEN	-
Nina Kjellson	F	49	CIDARA THERAPEUTICS, INC.	1 years
Pehr Harbury	M	-	DICE Molecules SV, Inc. DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.	-
Phil Patten	M	-	DICE Molecules SV, Inc. DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.	-
Zeryn Sarpangal	F	44	ACHAOGEN	10 years
Paul Daruwala	M	55	CIDARA THERAPEUTICS, INC.	8 years
Steven Elms	M	60	CIDARA THERAPEUTICS, INC.	1 years
Timothy Franson	M	72	CIDARA THERAPEUTICS, INC.	9 years
Jon B. Bruss	M	-	ACHAOGEN	-
John Bedbrook	M	-	DICE Molecules SV, Inc. DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.	-
Robert Perez	M	59	CIDARA THERAPEUTICS, INC.	3 years
Camille Samuels	F	52	ACHAOGEN	11 years
Patrick Heron	M	53	CIDARA THERAPEUTICS, INC.	1 years
Allan S. Wagman	M	-	ACHAOGEN	7 years
Sunny Lee Ryan	F	54	ACHAOGEN	3 years
Daniel Bensen	M	49	CIDARA THERAPEUTICS, INC.	4 years
Robert More	M	56	ACHAOGEN	-
Peter G. Schultz	M	67	ACHAOGEN	-
Brady Johnson	M	-	CIDARA THERAPEUTICS, INC.	7 years
Daniel G. Marquess	M	55	THERAVANCE BIOPHARMA, INC.	17 years
Daniel Geffken	M	67	CIDARA THERAPEUTICS, INC.	4 years
Christine Murray	F	63	ACHAOGEN	4 years
Marc Wilson	M	44	CIDARA THERAPEUTICS, INC.	4 years
Pattie Chiang	F	-	ACHAOGEN	7 years
Christine Welch	F	-	ACHAOGEN	-
Becki Filice	F	63	ACHAOGEN	3 years
Floyd E. Romesberg	M	58	ACHAOGEN	9 years
Paul Stone	M	60	CIDARA THERAPEUTICS, INC.	2 years
Shaw H. Warren	M	-	CIDARA THERAPEUTICS, INC.	-
Nathaniel David	M	56	ACHAOGEN	2 years
Kenneth Bartizal	M	72	CIDARA THERAPEUTICS, INC.	-
Dirk Thye	M	54	CIDARA THERAPEUTICS, INC.	2 years
John Jacobsen	M	56	THERAVANCE BIOPHARMA, INC.	17 years

Statistics

Country	Connections	% of total
United States	54	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections